AGILeBiotics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

AGILeBiotics General Information

Description

Developer of novel antibiotics designed to treat patients infected by life-threatening hospital-acquired multidrug-resistant infections. The company's antibiotics are based on natural products that fight against infections caused by multi-drug resistant bacteria, enabling healthcare professionals to cure patients in intensive care units and offer them access to safe therapeutic alternatives.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • L.J. Zielstraweg 2
  • 9713 GX Groningen
  • Netherlands
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • L.J. Zielstraweg 2
  • 9713 GX Groningen
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AGILeBiotics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 18-Jul-2025 Completed Out of Business
6. Grant 28-Nov-2019 Completed Startup
5. Early Stage VC 18-Jul-2018 Completed Startup
4. Seed Round 01-Mar-2017 Completed Startup
3. Grant 01-Feb-2017 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2017 Completed Startup
To view AGILeBiotics’s complete valuation and funding history, request access »

AGILeBiotics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel antibiotics designed to treat patients infected by life-threatening hospital-acquired multidrug-resis
Pharmaceuticals
Groningen, Netherlands
2 As of 2023

Cerdanyola, Spain
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AGILeBiotics Competitors (14)

One of AGILeBiotics’s 14 competitors is Ability Pharma, a Private Equity-Backed company based in Cerdanyola, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Genentech Formerly VC-backed South San Francisco, CA
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Cardurion Venture Capital-Backed Burlington, MA
Volastra Venture Capital-Backed New York, NY
You’re viewing 5 of 14 competitors. Get the full list »

AGILeBiotics Patents

AGILeBiotics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3120940-A1 Novel antibacterial 3"-derivatives of 4,6-disubstituted 2,5-dideoxystreptamine aminoglycoside antibiotics Pending 05-Dec-2018
EP-3891162-A1 Novel antibacterial 3"-derivatives of 4,6-disubstituted 2,5-dideoxystreptamine aminoglycoside antibiotics Active 05-Dec-2018
US-20220127297-A1 Novel antibacterial 3"-derivatives of 4,6-disubstituted 2,5-dideoxystreptamine aminoglycoside antibiotics Inactive 05-Dec-2018
WO-2020115190-A1 Novel antibacterial 3"-derivatives of 4,6-disubstituted 2,5-dideoxystreptamine aminoglycoside antibiotics Inactive 05-Dec-2018
EP-3891162-B1 Novel derivatives of n-3"-guanidino-2,5-dideoxy-5-fluoro-4,6-disubstituted-streptamine aminoglycoside antibiotics Active 05-Dec-2018 C07D487/04
To view AGILeBiotics’s complete patent history, request access »

AGILeBiotics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AGILeBiotics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Groningen University
To view AGILeBiotics’s complete investors history, request access »

AGILeBiotics FAQs

  • When was AGILeBiotics founded?

    AGILeBiotics was founded in 2017.

  • Where is AGILeBiotics headquartered?

    AGILeBiotics is headquartered in Groningen, Netherlands.

  • What is the size of AGILeBiotics?

    AGILeBiotics has 2 total employees.

  • What industry is AGILeBiotics in?

    AGILeBiotics’s primary industry is Pharmaceuticals.

  • Is AGILeBiotics a private or public company?

    AGILeBiotics is a Private company.

  • What is AGILeBiotics’s current revenue?

    The current revenue for AGILeBiotics is .

  • Who are AGILeBiotics’s investors?

    University of Groningen has invested in AGILeBiotics.

  • Who are AGILeBiotics’s competitors?

    Ability Pharma, Genentech, Gesynta Pharma, Cardurion, and Volastra are some of the 14 competitors of AGILeBiotics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process